Exploring Medical Cannabis in Substance use Treatment.

Event Information

Share this event

Date and Time





United Kingdom

View Map

Event description


Drug Science Medical Cannabis Educational Seminar, for substance misuse medical professionals.

Wednesday 27th Nov 2019 | London

The Chief Medical Officer and advisor to the UK government has recently agreed that cannabis is a medicine. It has now been removed from Schedule 1 of the Misuse of Drugs Act 1971 to Schedule 2 allowing doctors to prescribe it. But few are doing so at present, meaning that tens of thousands of people with chronic illnesses are still resorting to “illegal” sources for their supply.

Register your attendance

Please be advised that we will contact you prior the event to remind you of your attendance. If you are unable to attend once registered please let us know as catering will be provided and we will need to confirm numbers.

This event is free for people who work within the Substance Misuse arena, not patients.

Event Details

This day seminar, hosted by Drug Science, is made possible through an unrestricted educational grant from Althea. It will include information on Cannabis Use Disorder, Medicinal Cannabis efficacy and Harm Reduction Strategy .

Delegates will learn:

  • A history of cannabis as a medicine
  • How the Endocannabinoid system works
  • Understanding of Cannabis Use Disorder and dependancy
  • The current UK regulatory position
  • Practical steps in Substance Misuse harm reduction

In addition:

  • Your attendance guarantees an opportunity to meet and share challenges with other medical practitioners and other experts in the UK.
  • You will learn about Drug Science’s ambition to create medical cannabis clinical networks, accelerating access to patients who need it, and how you can become involved in this.
  • You will gain access to Drug Science’s CPD accredited online medical cannabis education platform, with multiple learning modules available for different indications.

Speakers to include:

Prof David Nutt (chair)

Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Prof Nutt was a member of the Committee on Safety of Medicine, and was President of the European College of Neuropsychopharmacology.

Dr Tom Freeman

Senior Lecturer, Lead Director of the Addiction and Mental Health Group (AIM) within the Department of Psychology at the University of Bath.

United Patients Alliance

Patients present a snapshot of their experiences.

Others to be announced soon

Who should attend:

Substance Misuse Medical Professionals, not suitable for patients.

Share with friends

Date and Time




United Kingdom

View Map

Save This Event

Event Saved